Belgium· BE-AMP-SAM665860-00

Ankreta 10000 U

A multienzyme - lipase, protease etc product containing pancreas powder from porcine, registered in Belgium by Allgen Pharmaceuticals. The same ATC class is registered in 11 of our 19 countries.

ATC A09AA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAnkreta 10000 UATCA09AA02REGISTER NO.BE-AMP-SAM665860-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Multienzyme - lipase, protease etc is registered in 11 of 19 countries.

Countries holding a registration under ATC A09AA02 (multienzyme - lipase, protease etc), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Multienzyme - lipase, protease etc · ATC A09AA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Pancreas Powder from Porcine
Manufacturer
Allgen Pharmaceuticals
Country
Belgium (BE)
ATC code
A09AA02
ATC class
Multienzyme - Lipase, Protease etc
Defined daily dose
240 TSD, FIP
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for multienzyme - lipase, protease etc.

Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Multienzyme - lipase, protease etc · interactions on record

20 records

  • 20 moderate

Most severe, free to view

  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Calcium carbonateA02AC01moderate
  • MagaldrateA02AD02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e21e4ffa-19cc-4508-9256-22c13a7bf53f
GET /v1/drugs/e21e4ffa-19cc-4508-9256-22c13a7bf53f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gastro-resistant capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Ankreta 10000 U",
  "name_fr": "Ankreta 10000 U",
  "name_nl": "Ankreta 10000 U",
  "amp_code": "SAM665860-00",
  "strengths": [
    "123.2800",
    "123.2800",
    "2.4500",
    "0.1600",
    "0.0004"
  ],
  "pack_count": 1,
  "substances": [
    "Pancreas Powder from Porcine",
    "Cetyl Alcohol",
    "E 124",
    "Sorbic Acid"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Multienzymes (Lipase, Protease etc.)",
  "authorisation_numbers": [
    "BE665860"
  ]
}

See everything about multienzyme - lipase, protease etc.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.